By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Mallinckrodt Pharmaceuticals 

675 McDonnell Boulevard

Hazelwood  Missouri  63042  U.S.A.
Phone: 314-654-2000 Fax: 314-654-5381


SEARCH JOBS

Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies, as well as nuclear imaging products. Areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and hemostasis products; and central nervous system drugs.

YEAR FOUNDED:

1840

LEADERSHIP:

Founder: Emil Mallinckrodt

CEO: Mark Trudeau

CFO: Matthew Harbaugh

JOBS:

Please click here for Mallinckrodt job opportunities.

PRODUCTS:

All Products


Key Statistics


Email:
Ownership: Subsidiary

Web Site: Mallinckrodt
Employees:
Symbol: MNK
 



Industry
Medical Device


Collaborations

Advanced Magnetics, Inc.  GastroMARK in North America





Company News
Mallinckrodt (MNK) Release: Health Economic Data On OFIRMEV (Acetaminophen) Injection Presented At 28th Annual National Forum Of The Institute For Healthcare Improvement 12/7/2016 7:54:05 AM
Mallinckrodt (MNK) Reports Fiscal 2016 Fourth Quarter And Full-Year Results 11/29/2016 10:27:54 AM
Mallinckrodt (MNK) Will Initiate Company-Sponsored Clinical Trial Of H.P. Acthar Gel In Treatment Of Amyotropic Lateral Sclerosis (ALS) 11/21/2016 8:55:02 AM
Mallinckrodt (MNK) Release: Study Addresses Possible Impact Of H.P. Acthar Gel On Use Of Corticosteroids Among Patients With Rheumatoid Arthritis, Lupus, And Dermatomyositis/Polymyositis 11/18/2016 8:42:17 AM
Mallinckrodt (MNK) Release: Clinical Pharmacokinetic And Health Economic Data On OFIRMEV (Acetaminophen) Injection Presented At 15th Annual Pain Medicine Meeting Of ASRA 11/18/2016 7:26:30 AM
Mallinckrodt (MNK) Release: Clinical Data Analysis On Terlipressin Presented At The Liver Meeting 11/17/2016 8:19:16 AM
First Patient Enrolled In Mallinckrodt (MNK) Phase 4 Trial Of H.P. Acthar Gel For Lupus 11/15/2016 6:42:43 AM
First Patient Enrolled In Mallinckrodt (MNK) Phase 4 Trial Of H.P. Acthar Gel For Rheumatoid Arthritis 11/14/2016 7:35:08 AM
Mallinckrodt (MNK) Announces U.S. FDA Approval Of OFIRMEV IV Bag Presentation 11/9/2016 11:20:08 AM
Mallinckrodt (MNK) Donates Drug Deactivation Pouches To Enable Safe Disposal Of Prescription Drugs In West Virginia 10/26/2016 8:43:04 AM
12345678910...
//-->